Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review
FL Duan, H Yang, X Gong, Z Zuo, S Qin, J Ji… - …, 2023 - Wiley Online Library
Aims The aim of this study was to evaluate the clinicopathological features,
immunophenotype, differential diagnosis, molecular genetic features and prognosis of …
immunophenotype, differential diagnosis, molecular genetic features and prognosis of …
Fusion-driven spindle cell rhabdomyosarcomas of bone and soft tissue: a clinicopathologic and molecular genetic study of 25 cases
The evolving classification of rhabdomyosarcoma (RMS) now includes spindle cell RMS
(SRMS). Bone/soft tissue SRMS often harbor TFCP2, or less often MEIS1 rearrangements …
(SRMS). Bone/soft tissue SRMS often harbor TFCP2, or less often MEIS1 rearrangements …
Epithelioid and spindle cell rhabdomyosarcoma with EWSR1:: TFCP2 fusion mimicking metastatic lung cancer: a case report and literature review
L Haug, J Doll, S Appenzeller, V Kunzmann… - … -Research and Practice, 2023 - Elsevier
Abstract Rhabdomyosarcoma (RMS) with EWSR1/FUS:: TFCP2 fusion is an emerging,
molecularly defined, rare subtype of RMS. It can affect patients in a wide age range and …
molecularly defined, rare subtype of RMS. It can affect patients in a wide age range and …
Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma—diagnostic challenge and report of two cases
H Carrillo‐Ng, Y Liang, S Chang… - Genes …, 2023 - Wiley Online Library
Rhabdomyosarcomas (RMS) are malignant mesenchymal tumors with skeletal muscle
differentiation which are classified into alveolar, embryonal, pleomorphic, and spindle …
differentiation which are classified into alveolar, embryonal, pleomorphic, and spindle …
Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma
V Csizmok, CJ Grisdale, LM Williamson… - Genes …, 2024 - Wiley Online Library
The identification of gene fusions in rare sarcoma subtypes can have diagnostic, prognostic,
and therapeutic impacts for advanced cancer patients. Here, we present a case of a 31‐year …
and therapeutic impacts for advanced cancer patients. Here, we present a case of a 31‐year …
Clinicopathological and molecular characteristics of intraosseous rhabdomyosarcoma involving head and neck region: a systematic review and meta-analysis
N Sivakumar, P Sharma, S Chandra… - Pediatric and …, 2023 - journals.sagepub.com
Rhabdomyosarcoma with TFCP2 rearrangement is a newly introduced spindle cell
neoplasm showing predilection for craniofacial bones exhibiting highly aggressive nature …
neoplasm showing predilection for craniofacial bones exhibiting highly aggressive nature …
Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of …
M Bradová, E Mosaieby, M Michal, T Vaněček… - …, 2024 - Wiley Online Library
Aims Spindle‐cell/sclerosing rhabdomyosarcomas (SS‐RMS) are clinically and genetically
heterogeneous. They include three well‐defined molecular subtypes, of which those with …
heterogeneous. They include three well‐defined molecular subtypes, of which those with …
Rhabdomyosarcoma With FUS::TFCP2 Fusion in the Mandible: A Rare Aggressive Subtype, but Can Be Misdiagnosed as Ossifying Fibroma
P Zhong, S Wei, H Xiao, Y Zeng - International Journal of …, 2024 - journals.sagepub.com
Rhabdomyosarcoma (RMS) with TFCP2 rearrangement has been identified recently. This
entity has a distinctive clinicopathologic features: a rapidly aggressive clinical course, a …
entity has a distinctive clinicopathologic features: a rapidly aggressive clinical course, a …
Primary Intraosseous Spindle Cell Rhabdomyosarcoma: A Case Report in an Unusual Location
JM Plotzke, R Rabah, DR Robinson… - Pediatric and …, 2024 - journals.sagepub.com
Spindle cell/sclerosing rhabdomyosarcoma is an infrequent subtype of rhabdomyosarcoma
according to the World Health Organization Classification of Soft Tissue and Bone Tumours …
according to the World Health Organization Classification of Soft Tissue and Bone Tumours …
[HTML][HTML] Pediatric spindle cell/sclerosing rhabdomyosarcoma with FUS–TFCP2 fusion: a case report and literature review
Z Fang, C Duan, S Wang, L Fu, P Yang, T Yu… - Translational …, 2024 - ncbi.nlm.nih.gov
Background FUS–TFCP2 gene fusion is a recently identified and highly distinct molecular
subtype of spindle cell/sclerosing rhabdomyosarcoma (RMS), with fewer than 40 cases …
subtype of spindle cell/sclerosing rhabdomyosarcoma (RMS), with fewer than 40 cases …